Xaraf Management
Latest statistics and disclosures from Xaraf Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are GLD, Proshares Ultrashort 20+y Tr etf, XOM, IBM, NVS. These five stock positions account for 87.39% of Xaraf Management's total stock portfolio.
- Added to shares of GLD (+$32.40M), Proshares Ultrashort 20+y Tr etf (+$23.18M), XOM (+$8.92M), IBM (+$5.75M), NVS (+$5.70M), MON, Kinder Morgan, Metlife Inc 5% 10/0/14 Conv Pr cv prf, TEVA, ALR.
- Started new stock positions in INO, GLD, XOM, TEVA, IBM, MON, * Genco Shipping & Trading Ltd shs, Kinder Morgan, NVS, Citigroup Inc *w exp 10/28/201, ALR, Kinder Morgan Inc/delaware Wts, Proshares Ultrashort 20+y Tr etf, Metlife Inc 5% 10/0/14 Conv Pr cv prf, Ford Mtr Co Del *w exp 01/01/201.
- As of Dec. 31, 2012, Xaraf Management has $86.91M in assets under management (AUM). Assets under management dropped from a total value of $91.11B to $86.91M.
- Independent of market fluctuations, Xaraf Management was a net buyer by $86.91M worth of stocks in the most recent quarter.
Xaraf Management portfolio companies for quarter ending December 2012
| Ticker | Name | Portfolio Weight | Change | Share Count | Price | Last Trade |
|---|---|---|---|---|---|---|
| GLD | SPDR Gold Trust | 37.28 | NEW | 200000 | 162.01 | 133.98 |
| Proshares Ultrashort 20+y Tr etf | 26.67 | NEW | 365200 | 63.47 | 0.00 | |
| XOM | Exxon Mobil Corporation | 10.27 | NEW | 103100 | 86.55 | 91.76 |
| IBM | International Business Machines | 6.61 | NEW | 30000 | 191.57 | 207.26 |
| NVS | Novartis AG | 6.55 | NEW | 90000 | 63.30 | 74.21 |
| MON | Monsanto Company | 4.36 | NEW | 40000 | 94.65 | 107.98 |
| Kinder Morgan | 2.56 | NEW | 63000 | 35.33 | 0.00 | |
| Metlife Inc 5% 10/0/14 Conv Pr cv prf | 1.79 | NEW | 35000 | 44.34 | 0.00 | |
| TEVA | Teva Pharmaceutical Industries | 1.70 | NEW | 39500 | 37.34 | 39.99 |
| ALR | Alere | 1.09 | NEW | 51200 | 18.50 | 25.88 |
| * Genco Shipping & Trading Ltd shs | 0.60 | NEW | 150000 | 3.49 | 0.00 | |
| Ford Mtr Co Del *w exp 01/01/201 | 0.30 | NEW | 66650 | 3.95 | 0.00 | |
| Kinder Morgan Inc/delaware Wts | 0.09 | NEW | 20000 | 3.80 | 0.00 | |
| INO | Inovio Pharmaceuticals | 0.07 | NEW | 129633 | 0.50 | 0.68 |
| Citigroup Inc *w exp 10/28/201 | 0.06 | NEW | 1000000 | 0.05 | 0.00 |
Past 13F-HR SEC Filings for Xaraf Management
- Xaraf Management 2012 Q3 - filed Nov. 14, 2012
- Xaraf Management 2012 Q2 - filed Aug. 14, 2012
- Xaraf Management 2012 Q1 - filed May 15, 2012
- Xaraf Management 2011 Q4 amended - filed Feb. 14, 2012
- Xaraf Management 2011 Q2 - filed Aug. 15, 2011
- Xaraf Management 2011 Q1 - filed May 13, 2011
- Xaraf Management 2010 Q4 - filed Feb. 15, 2011
- Xaraf Management 2011 Q4 - filed Feb. 14, 2011